Home
Conditions
Nasopharyngeal Diseases

Clinical trial condition

Nasopharyngeal Diseases

Explore clinical trials studying Nasopharyngeal Diseases. Study availability and eligibility vary by location and protocol.

489 public trials 162 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Diseases trial results

Not Yet Recruiting

Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma

NCT07567742

Conditions: Carcinoma, Head and Neck Neoplasms, Mouth Diseases, +18 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT07565389

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: National University Cancer Institute, Singapore, National University Health System Singapore

View Trial Details

Not Yet Recruiting

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

NCT07555860

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pseudomembrane Removal for Post-RT Nasopharyngeal Necrosis

NCT07552883

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

NCT07540390

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

NCT07524413

Conditions: Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC), +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients

NCT07247201

Conditions: Carcinoma, Head and Neck Neoplasms, Maximum Tolerated Dose, +19 more
Locations: Singapore General Hospital Singapore

View Trial Details

Not Yet Recruiting

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

NCT07320963

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

NCT07399158

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT07388758

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Nasopharyngeal Diseases

Nasopharyngeal Diseases trial results

Related conditions